1.
Clinics
;
67(supl.1): 125-129, 2012. tab
Article
in English
| LILACS
| ID: lil-623142
ABSTRACT
The recent availability of molecular targeted therapies leads to a reconsideration of the treatment strategy for patients with distant metastases from medullary thyroid carcinoma. In patients with progressive disease, treatment with kinase inhibitors should be offered.